New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
09:07 EDTSUPNSupernus issued third U.S. patent for Oxtellar XR
Supernus Pharmaceuticals announced the issuance of a third patent by the United States Patent and Trademark Office covering Oxtellar XR, its novel once-daily extended-release oxcarbazepine product. The patent was issued by the USPTO on December 31, 2013. It provides protection for the product with expiration that is no earlier than 2027.
News For SUPN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 10, 2014
07:35 EDTSUPNSupernus announces Paragraph IV ANDA filing for Oxtellar XR
Subscribe for More Information
December 9, 2014
07:36 EDTSUPNSupernus announces Paragraph IV ANDA filing for Trokendi XR
Subscribe for More Information
December 8, 2014
17:24 EDTSUPNOrchard Hill lowers stake in Supernus to 4.99% from 7.0%
Stake includes convertible notes.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use